STERIS plc $STE Holdings Raised by GHP Investment Advisors Inc.

GHP Investment Advisors Inc. lifted its stake in shares of STERIS plc (NYSE:STE) by 4.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 64,150 shares of the medical equipment provider’s stock after purchasing an additional 2,666 shares during the quarter. GHP Investment Advisors Inc. owned about 0.07% of STERIS worth $15,410,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of STE. Vontobel Holding Ltd. raised its stake in shares of STERIS by 17.1% during the first quarter. Vontobel Holding Ltd. now owns 2,071 shares of the medical equipment provider’s stock valued at $469,000 after purchasing an additional 302 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of STERIS by 0.9% during the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 11,412 shares of the medical equipment provider’s stock valued at $2,587,000 after purchasing an additional 98 shares in the last quarter. Mutual Advisors LLC raised its stake in shares of STERIS by 23.4% during the first quarter. Mutual Advisors LLC now owns 2,503 shares of the medical equipment provider’s stock valued at $563,000 after purchasing an additional 474 shares in the last quarter. Checchi Capital Advisers LLC bought a new stake in shares of STERIS during the first quarter valued at about $216,000. Finally, OneDigital Investment Advisors LLC raised its stake in shares of STERIS by 2.4% during the first quarter. OneDigital Investment Advisors LLC now owns 22,964 shares of the medical equipment provider’s stock valued at $5,205,000 after purchasing an additional 533 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors.

Insider Activity at STERIS

In other STERIS news, Director Mohsen Sohi sold 4,110 shares of STERIS stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $241.96, for a total transaction of $994,455.60. Following the transaction, the director owned 22,361 shares of the company’s stock, valued at $5,410,467.56. The trade was a 15.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Daniel A. Carestio sold 159 shares of STERIS stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $241.82, for a total value of $38,449.38. Following the transaction, the chief executive officer directly owned 51,096 shares in the company, valued at approximately $12,356,034.72. This trade represents a 0.31% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 18,868 shares of company stock worth $4,585,389. Company insiders own 1.07% of the company’s stock.

STERIS Trading Down 0.2%

Shares of STE opened at $235.75 on Friday. The business’s 50-day moving average price is $243.79 and its 200 day moving average price is $238.03. The stock has a market capitalization of $23.22 billion, a P/E ratio of 36.10 and a beta of 1.01. STERIS plc has a 1-year low of $200.98 and a 1-year high of $253.00. The company has a current ratio of 2.22, a quick ratio of 1.53 and a debt-to-equity ratio of 0.27.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, August 6th. The medical equipment provider reported $2.34 earnings per share for the quarter, topping analysts’ consensus estimates of $2.32 by $0.02. STERIS had a return on equity of 14.17% and a net margin of 11.61%.The firm had revenue of $1.40 billion for the quarter, compared to analysts’ expectations of $1.36 billion. During the same quarter last year, the business posted $2.03 EPS. STERIS’s revenue was up 8.8% on a year-over-year basis. Analysts expect that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th will be paid a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Tuesday, November 18th. STERIS’s payout ratio is 38.59%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on STE shares. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. KeyCorp lifted their target price on STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a report on Tuesday, July 22nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a report on Tuesday, October 14th. Finally, Morgan Stanley lifted their target price on STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a report on Friday, August 8th. Seven investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $273.50.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.